ICD-10-CM Billable Code

M12.20

Villonodular synovitis (pigmented), unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Villonodular synovitis (pigmented) is a joint condition characterized by the abnormal growth of the synovial membrane, which lines the joints. This condition leads to swelling, pain, and reduced mobility, primarily affecting the knee but can occur in other joints as well. It is called 'pigmented' due to the presence of hemosiderin deposits, which give the affected tissue a darker appearance. Diagnosed through imaging and sometimes tissue biopsy, treatment often involves surgical removal of the abnormal tissue to restore joint function and reduce symptoms.

Causes & Symptoms

Clinical Causes: Unknown exact cause, but believed to involve abnormal proliferation of synovial cells. Inflammatory responses possibly triggered by injury or injury-like processes. Genetic factors may play a role, although specific genetic links are not well established. Repeated joint trauma or microtrauma may contribute to the development of the condition.

Key Symptoms: Joint swelling, often persistent or recurrent. Pain during or after movement, which may worsen over time. Restricted range of motion, making it difficult to fully bend or straighten the joint. A sensation of clicking or catching within the joint. Joint stiffness, especially after periods of rest. In some cases, warmth and redness over the affected area. Progressive joint deterioration if untreated.

Diagnostic & Treatment

Diagnosis Path: The diagnosis of villonodular synovitis involves a combination of clinical examination and imaging studies. MRI (Magnetic Resonance Imaging) is particularly useful due to its ability to visualize the characteristic pigmented, hemosiderin-laden synovial tissue. Sometimes, a tissue biopsy is performed during arthroscopy to confirm the presence of pigmented villonodular synovitis and exclude other joint diseases. Additional tests may include X-rays to assess for joint damage or abnormalities.

Treatment Protocols: Managing villonodular synovitis typically involves surgical intervention. The primary goal is to remove the proliferative synovial tissue, often through arthroscopic synovectomy. This minimally invasive procedure reduces the risk and promotes quicker recovery. In more extensive cases, open surgery may be necessary. Post-surgical care involves physical therapy to regain joint mobility and strength. Although recurrence is possible, timely and effective treatment generally leads to symptom relief and improved joint function. In some cases, radiation therapy or medications may be considered to manage persistent or recurrent disease.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M12.20 a billable ICD-10 code?
Yes, M12.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M12.20?
Clinical documentation must specify the nature of Villonodular synovitis (pigmented), unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference